AXSM
Axsome Therapeutics, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +9.1% ·
share flow -12.3% ·
net new positions +8.3%
— formula
Ownership fragmentation — more holders, smaller aggregate stake
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 131 | +8 | 27.61M | $6.75B | +16 | −7 |
| Q1 2026 | 125 | +4 | 27.78M | $4.69B | +9 | −6 |
| Q4 2025 | 120 | +1 | 28.15M | $5.13B | +2 | — |
| Q3 2025 | 19 | 0 | 15.93M | $1.93B | +1 | −2 |
| Q2 2025 | 17 | -1 | 13.98M | $1.46B | — | −1 |
| Q1 2025 | 15 | +3 | 4.41M | $513.88M | +3 | — |
| Q4 2024 | 12 | +1 | 3.90M | $329.80M | +1 | — |
| Q3 2024 | 10 | 0 | 3.50M | $314.34M | — | — |
| Q2 2024 | 10 | — | 4.77M | $384.18M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 947.25K | — | $80.15M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 912.54K | +0.5% | $77.23M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 912.54K | +0.5% | $77.23M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Wellington Management ✦ | 673.16K | -9.4% | $56.96M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 673.16K | -9.4% | $56.96M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 673.16K | -9.4% | $56.96M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | Wellington Management ✦ | 673.16K | -9.4% | $56.96M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | Wellington Management ✦ | 673.16K | -9.4% | $56.96M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | Wellington Management ✦ | 673.16K | -9.4% | $56.96M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 495.39K | +62.6% | $41.91M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 495.39K | +62.6% | $41.91M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | Norges Bank ✦ (passive) | 403.03K | +3.0% | $34.10M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Point72 Asset Management ✦ | 185.14K | -65.9% | $15.66M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | Marshall Wace ✦ | 127.10K | New | $10.75M | 0.0% | New | 1 | SEC ↗ |
| 15 | Marshall Wace ✦ | 127.10K | New | $10.75M | 0.0% | New | 1 | SEC ↗ |
| 16 | Adage Capital Partners ✦ | 60.00K | -88.6% | $5.08M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 38.21K | +40.7% | $3.23M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 38.21K | +40.7% | $3.23M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 38.21K | +40.7% | $3.23M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 20 | T. Rowe Price ✦ | 31.23K | +12.1% | $2.64M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | D. E. Shaw & Co. ✦ | 20.35K | +601.6% | $1.72M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 22 | D. E. Shaw & Co. ✦ | 20.35K | +601.6% | $1.72M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 23 | Millennium Management ✦ | 4.25K | -82.8% | $359,254 | 0.0% | ▼ Trim | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Marshall Wace | $10.75M | 0.0% |
| Marshall Wace | $10.75M | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 11.40K shares, $1,926 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.